Results
1 -
10 of
11
(Click
here to explore results)
- Ligand discrimination during virtual screening of the CB1 cannabinoid receptor crystal structures following cross-docking and microsecond molecular dynamics simulations. Jason S. E. Loo, Abigail L. Emtage, Lahari Murali, Sze Siew Lee, Alvina L. W. Kueh, Stephen P. H. Alexander
, RSC Adv.
, 2019
, 9
, 15949
- Applications of oxazolidinones as chiral auxiliaries in the asymmetric alkylation reaction applied to total synthesis. Majid M. Heravi, Vahideh Zadsirjan, Behnaz Farajpour
, RSC Adv.
, 2016
, 6
, 30498
- Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs. Pablo Etayo, Anton Vidal-Ferran
, Chem. Soc. Rev.
, 2013
, 42
, 728
- Physical insights into mechanistic processes in organometallic chemistry: an introduction. Robert H. Morris
, Faraday Discuss.
, 2019
, 220
, 10
- Link between a high k
on for drug binding and a fast clinical action: to be or not to be?. Georges Vauquelin
, Med. Chem. Commun.
, 2018
, 9
, 1426
- Metabolism-guided drug design. Antonia F. Stepan, Vincent Mascitti, Kevin Beaumont, Amit S. Kalgutkar
, Med. Chem. Commun.
, 2013
, 4
, 631
- Covalent cannabinoid receptor ligands – structural insight and selectivity challenges. Ian Liddle, Michelle Glass, Joel D. A. Tyndall, Andrea J. Vernall
, RSC Med. Chem.
, 2022
, 13
, 497
- Natural allosteric modulators and their biological targets: molecular signatures and mechanisms. Marjorie Bruder, Gina Polo, Daniela B. B. Trivella
, Nat. Prod. Rep.
, 2020
, 37
, 488
- A computational prospective on isoform-selective CB2 inhibitors. Yi Zhao, Ying Wang, Huibin Wang, Baichun Hu, Zhaohu Luo, Fengjiao Zhang
, New J. Chem.
, 2021
, 45
, 12688
- Asymmetric homogeneous hydrogenations at scale. David J. Ager, André H. M. de Vries, Johannes G. de Vries
, Chem. Soc. Rev.
, 2012
, 41
, 3340